1-5 of 5
Henry Wagner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation Of a Novel 3 Factor Prognostic Score (PS-3) For Patients With Advanced Hodgkin Lymphoma (HL) Treated On US Intergroup E2496

Catherine S. Diefenbach, MD, Hailun Li, MS, Fangxin Hong, PhD, Leo I. Gordon, MD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Michael Crump, MD FRCPC, Randy D. Gascoyne, MD, Henry Wagner, Jr., MD, Patrick J Stiff, MD, Bruce D. Cheson, M.D., Douglas A. Stewart, MD, FRCPC, Brad S. Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, MD, Richard T. Hoppe, MD, Sandra J. Horning, MD, Ranjana H. Advani, MD
Journal: Blood
Blood (2013) 122 (21): 4277.
https://doi.org/10.1182/blood.V122.21.4277.4277
Published: 2013
Journal Articles

A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients with Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma: an Eastern Cooperative Oncology Group Study (E3402).

Thomas E. Witzig, MD, Fangxin Hong, Ph.D., Ivana N. Micallef, MD, Randy D. Gascoyne, MD, Ahmet Dogan, MD, PhD, Henry Wagner, Jr., MD, Ranjana H. Advani, MD, Brad S. Kahl, M.D., Sandra J. Horning, M.D.
Journal: Blood
Blood (2012) 120 (21): 2687.
https://doi.org/10.1182/blood.V120.21.2687.2687
Published: 2012
Journal Articles

Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD + Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496

Ranjana Advani, MD, Fangxin Hong, PhD, Leo I. Gordon, MD, FACP, Randy D. Gascoyne, MD, Henry Wagner, MD, Richard T. Hoppe, MD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Brad S. Kahl, MD, Patrick Stiff, MD, Bruce D. Cheson, MD, Andrew R Belch, MD, Jonathan W. Friedberg, MD, MMSc, Jeannine Kassis, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, MD, Sandra J. Horning, MD
Journal: Blood
Blood (2011) 118 (21): 1603.
https://doi.org/10.1182/blood.V118.21.1603.1603
Published: 2011
Journal Articles

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Leo I Gordon, MD, FACP, Fanxing Hong, PhD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Henry Wagner, MD, Patrick J Stiff, MD, Bruce D. Cheson, MD, Mary Gospodarowicz, MD, FRCPC, Ranjana Advani, MD, Brad Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, Richard Hoppe, MD, Sandra J. Horning, MD
Journal: Blood
Blood (2010) 116 (21): 415.
https://doi.org/10.1182/blood.V116.21.415.415
Published: 2010
Journal Articles

Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496

Ranjana Advani, MD, Fangxin Hong, PhD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Sue Robinson, MD, Randy D. Gascoyne, MD, Henry Wagner, MD, Patrick J Stiff, MD, Bruce D. Cheson, MD, Douglas A. Stewart, MD, FRCP, Leo I Gordon, MD, FACP, Brad Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, MD, Richard Hoppe, MD, Sandra J. Horning, MD
Journal: Blood
Blood (2010) 116 (21): 416.
https://doi.org/10.1182/blood.V116.21.416.416
Published: 2010